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Abstract
The aim of this work was to evaluate the impact of atmospheric pressure nitrogen plasma on 
viability, proliferation, and osteogenic differentiation of normal mouse calvarial preosteoblasts 
(MC3T3-E1 Subclone 4), which were maintained in Hanks’ balanced salt solution (HBSS) 
during plasma exposure. Obtained results clearly demonstrated that short-time (4, 8, and 
16 s) nitrogen plasma treatment is non-toxic to the MC3T3-E1 cells, does not affect cell 
morphology, promotes preosteoblasts’ proliferation, enhances osteogenic differentiation 
by increasing bone alkaline phosphatase and osteocalcin concentration, but inhibits 
mineralization of extracellular matrix. The best results were achieved for 16 s exposure time 
and when the preosteoblasts were left in HBSS for 3 h after plasma treatment. Presented 
studies indicate great clinical potential of cold atmospheric nitrogen plasma for regenerative 
medicine applications to improve bone healing process.
Keywords: plasma activated cells, GlidArc, plasma activated medium, cell viability,  
ECM mineralization
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Plasma technology synergistically utilizes impact of active 
species, high electric fields, and electromagnetic radiation to 
enhance efficiency and achieve targeted treatment goals [1]. 
When oxygen or nitrogen are used as substrate gas in ambient 
conditions, reactive oxygen and nitrogen species (RONS) are 
formed which can affect properties of inanimate materials 
and living organisms. Electrical discharge can occur directly 
in treated liquid or in the gas intrusions in the liquid phase. 
Moreover, plasma can interact with liquid indirectly when the 
discharge occurs in gaseous phase in the vicinity of the sur-
face: the active species are then transferred via surface to the 
bulk of liquid. In the case of oxygen, this leads to formation 
of reactive radical species such as hydroxyl, hydrogen, super-
oxide, perhydroxyl and oxide anions, and molecular species 
such as hydrogen peroxide and ozone. Nitrogen-based species 
such as nitrogen oxide radicals, nitrate and nitrite anions, per-
oxynitrite, and also nitric, nitrous and peroxynitrous acids are 
also formed [1–7].
Atmospheric pressure plasma is utilized in various fields 
such as agriculture, food industry, engineering of biomat-
erials, exhaust gas, soil, water, and wastewater treatment 
[8–14]. For biotechnology and medical fields, plasma reactors 
working with targets in humid/wet environments are of high 
importance. Low temperature plasma for medical purposes 
was applied for inactivation of microorganisms in biofilm or 
planctonic forms and for decreasing of virulence [15–17]. 
There are reports on plasma-based bleeding control devices 
[18], plasma-supported cell boosting, plasma-induced wound 
healing, and application of plasma in regenerative medi-
cine [19], where low temperature plasma can be utilized for 
increasing the material biocompatibility and enhancement of 
drug delivery [20, 21]. Many research teams work on elimina-
tion of cancer cells and enhancement of antitumor drug activity 
via low temperature plasma technology [22–25], some reports 
focus on gene therapy [26], mutagenicity [27] and state that 
application of low temperature plasma can promote differen-
tiation of stem cells [28]. According to Tominami et al, short 
time application of plasma generated in a jet-type reactor can 
stimulate preosteoblasts’ differentiation and accelerate peri-
odontitis healing by promoting bone regeneration and bacte-
ricidal action [29].
The gliding arc discharge (GlidArc, GAD) belongs to the 
group of non-thermal plasmas, although it is formed from 
an electric arc discharge. The arc is generated between two 
diverging electrodes and it is blown along them by very fast 
transverse gas flow. The gas nozzle is placed between the 
electrodes in their axis of symmetry. The arc initiates at the 
shortest gap between the two electrodes and after it elongates 
by the fast gas flow from its initial position [12]. As the arc is 
elongated, its current is at its maximum and the voltage at the 
minimum. Arc elongation effects in increase in arc resistance, 
what implicates that elongating arc demands more and more 
power to be sustained, until it reaches the maximum that the 
power supply can provide and discharge extinguishes. After 
this transition point for the regime of GAD operation an initia-
tion of the next cycle takes place. This is the transition point 
for the regime of GAD operation. The discharge is often effec-
tively used for the process of disposal and treatment of dif-
ferent gaseous pollutants. Miscellaneous applications include 
bactericidal decontamination and treatment of seeds [12, 13].
The objective of this work was to identify the impact of 
atmospheric pressure plasma, generated in versatile GAD 
reactor working with nitrogen gas, on viability, proliferation, 
and osteogenic differentiation of normal mouse calvarial 
preosteoblasts (MC3T3-E1 Subclone 4). MC3T3-E1 cell line 
is a good model for studying osteogenic differentiation and 
bone formation under in vitro conditions since MC3T3-E1 
cells exhibit similar behavior to primary calvarial osteoblasts 
[30].
2. Materials and methods
2.1. Plasma generator and performance
The compact experimental set up with mini GAD reactor that 
was used in this study is presented in figure 1. The mini GAD 
mini reactor is a small, light and portable reactor in a round 
casing with a diameter of 90 mm and a height of 130 mm. It 
was operated at the atmospheric pressure and consisted of 
two diverging profiled copper rod electrodes of 10 cm and 
12° angle between them. The initial, smallest inter-electrode 
gap was settled as 3 mm and electrode tips were positioned at 
3 cm distance from the surface of the sample. The flow-rate 
of nitrogen was 7.33 dm3 min−1. Electrical parameters were 
measured using a Tektronix P6015A voltage probe, Tektronix 
P6022 current probe and Tektronix TDS 2024B oscilloscope. 
Utilized GAD power supply was based on electronic high-
voltage transformer of 50 Hz operation cycle. Maximum 
apparent power, calculated as the product of root mean square 
(RMS) values of current and voltage, was 52 VA and 25 VA 
on primary (U1, I1) and secondary side (U2, I2) of transformer, 
respectively. RMS voltage and current on the secondary side 
ranged 688 V and 36 mA, respectively. Voltage and current 
measurements were made using a Tektronix P6015A voltage 
probe, Tektronix P6022 current probe and Tektronix TDS 
2024B oscilloscope. The figures 1(b) and (c) show a close-up 
on voltage and current waveforms. Their irregular shape 
of signals resulted not only from the characteristics of the 
generator, but above all from the random nature of the arc 
discharge. However, periodicity can be noticed, where higher 
voltage and current values corresponded to the duration of 
arcing, which appeared with the network frequency (50 Hz).
Since composition of gaseous phase may have a strong 
impact on RONS diffusion to the liquid phase [31], NO2, 
NO, and CO concentrations were measured in the gas phase 
(one centimeter above the liquid) with the use of IBRID 
MX-6 sensor and concentration of ozone with the use of 
Ozone ECO-Sensors A-21ZX. Sensors’ sensitivity was as 
follows: 1 ppm for CO, 0.01 ppm for ozone, 0.1 ppm for NO 
and NO2. The gas was pumped through a 30 cm tube and sup-
plied to the sensors through device adapters (figure 1(a)). 
During the measurements, no additional ventilation was used. 
GAD plasma source—which is known for efficient genera-
tion of NOx— allowed for relatively high formation of NO 
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Figure 1. (a) Schematic diagrams of the experimental setup: 1—GAD reactor, 2—96-multiwell plate with MC3T3-E1 cells, 3—gas supply, 
4—electric power source, 5—flowmeter; (b) typical voltage of mini-GAD; (c) typical current characteristics of mini-GAD; (d)–(g)—
concentration of NO2, NO, CO, and O3 in a gaseous phase, respectively.
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reaching 274 ppm in a short 16 s time, whereas concentration 
of other gas components were relatively low (NO2  −  9 ppm, 
CO  −  62 ppm, O3  −  0.02 ppm) but increased with the treat-
ment time. Figures 1(d)–(g) show the results averaged from 
three measurements with the standard deviation as a measure-
ment error.
2.1.1. Plasma treatment of the cells. Adherent MC3T3-E1 
preosteoblasts cultured in polystyrene wells of 96-multiwell 
plate were exposed to plasma for 4 s, 8 s, and 16 s. Before 
GAD treatment with the use of nitrogen as a substrate gas, 
growth medium was discarded and replaced with 100 µl of 
Hanks’ balanced salt solution (HBSS, Sigma-Aldrich Chemi-
cals) to provide uniform environment during plasma exposure 
and to avoid unexpected results due to the high complexity 
of the composition of growth medium [32]. Temperature of 
the surface of the HBSS in a well with MC3T3-E1 cells was 
measured just after plasma exposure with uninsulated K-type 
thermocouple with electronic temperature compensation mul-
timeter and did not exceed 23 °C. Evaporation process caused 
by the gas flow and slightly elevated gas temperature was not 
observable during short 16 s treatment time.
2.2. Cell culture
The experiments were carried out using mouse calvarial 
preosteoblast cell line (MC3T3-E1 Subclone 4) purchased 
from ATCC (American Type Culture Collection). MC3T3-E1 
preosteoblasts were cultured in Minimum Essential Medium 
Eagle—Alpha Modification (alpha MEM medium, GIBCO) 
supplemented with 10% fetal bovine serum (Pan-Biotech) and 
antibiotics (100 U ml−1 penicillin, 100 µg ml−1 streptomycin) 
supplied by Sigma-Aldrich Chemicals. The cells were 
maintained in an incubator at 37 °C in a humidified atmosphere 
of 5% CO2 and 95% air.
2.2.1. Evaluation of cell viability after GAD treatment. To 
assess the effect of plasma treatment on preosteoblasts’ 
viability, MC3T3-E1 cells were seeded in 100 µl of the 
complete growth medium in 96-multiwell plates at a concen-
tration of 3  ×  104 cells/well and cultured for 24 h at 37 °C. 
Before GAD treatment, growth medium was discarded and 
replaced with 100 µl of HBSS. Preosteoblasts were exposed 
to plasma for 4 s, 8 s, and 16 s. Immediately (t  =  0) as well 
as 3 h (t  =  3 h) after GAD treatment, HBSS was discarded 
and fresh growth medium was added to each well. The cells 
were cultured for further 24 h and cell viability was assessed 
using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide-based assay known as MTT (Sigma-Aldrich Chemi-
cals). Briefly, 25 µl of MTT solution (5 mg ml−1 in phosphate 
buffered saline—PBS, Sigma-Aldrich Chemicals) were added 
to each well and the cells were returned to the CO2 incuba-
tor for 3 h. Then, formazan crystals produced by viable cells 
were dissolved using 100 µl of 10% sodium dodecyl sulfate 
(SDS)-HCl solution (Sigma-Aldrich Chemicals). After 12 h 
of incubation, the absorbance was measured at 570 nm using 
BioTek Synergy H4 Hybrid Microplate Reader. Viability of 
cells was expressed as the percentage of absorbance values 
obtained with respect to the control untreated cells (showing 
100% viability), which were maintained in HBSS in an analo-
gous manner to plasma-treated cells (t  =  0 and t  =  3 h).
2.2.2. Evaluation of cell proliferation after GAD treatment. 
MC3T3-E1 cells were seeded in 100 µl of the complete 
culture medium in 96-multiwell plates at very low concen-
tration of 3  ×  103 cells/well and cultured for 24 h at 37 °C. 
Before GAD treatment, growth medium was discarded and 
replaced with 100 µl of HBSS. Preosteoblasts were exposed 
to plasma for 4 s, 8 s, and 16 s. Immediately (t  =  0) as well as 
3 h (t  =  3 h) after plasma exposure, HBSS was replaced with 
fresh growth medium and the cells were cultured for further 
3 d. On the 1st, 2nd, and 3rd day of the experiment, cell pro-
liferation was assessed colorimetrically using Cell Count-
ing Kit-8 which is based on water-soluble tetrazolium salt 
(WST-8, Sigma-Aldrich Chemicals). Exact cell number was 
quantified from a calibration curve prepared for known con-
centrations of preosteoblasts. The test was performed accord-
ing to the manufacturer’s protocol. Untreated cells (that were 
not exposed to plasma) served as a control. Viable cell num-
bers as determined by WST-8 test for each time interval were 
then entered in Doubling Time Computing software to calcu-
late the growth rate and doubling time.
2.2.3. Evaluation of cell morphology after GAD treatment. 
Since WST-8 is non-toxic to the cells, after proliferation testing 
(on the 3rd day), the MC3T3-E1 preosteoblasts were washed 
with PBS and stained with AlexaFluor635phalloidin (Life 
Technologies, Thermo Fisher Scientific) and 4′,6-diamidino-
2-phenylindol (DAPI, Sigma-Aldrich Chemicals). Before 
fluorescent staining, the cells were fixed with 3.7% formal-
dehyde solution (Sigma-Aldrich Chemicals) for 10 min at 
room temperature and permeabilized with 0.2% TritonX-100 
(Sigma-Aldrich Chemicals) for 15 min. Cell cytoskeleton and 
nuclei were stained for 20 min at room temperature using two 
units of phallotoxin and 0.5 µg ml−1 DAPI. Morphology of 
stained cells was analyzed under a fluorescence laser scanning 
microscope, using a 2D scan technique (Olympus Fluoview 
equipped with an FV1000 laser scanner).
2.2.4. Evaluation of osteogenic differentiation after GAD treat-
ment. MC3T3-E1 cells were seeded in 96-multiwell plates 
and treated with GAD in the same manner as in the case of via-
bility assessment (section 2.2.1). Immediately (t  =  0) as well 
as 3 h (t  =  3 h) after plasma exposure, HBSS was replaced 
with freshly prepared osteogenic medium containing 0.05 mg 
ml−1 ascorbic acid and 10 mM β-glycerophosphate (Sigma-
Aldrich Chemicals). The cells were cultured for further 13 
or 21 d and then osteogenic differentiation was determined 
by evaluation of bone alkaline phosphatase (BAP) and osteo-
calcin (OC) concentration by enzyme-linked immunosorbent 
assays—ELISAs (muALPL ELISA kit, Uscn Life Science 
Inc. and muOC ELISA kit, Immunotopics Inc., respectively), 
which were performed according to the manufacturers’ proto-
cols. Briefly, standards (BAP or OC) and samples were added 
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to the appropriate wells of ELISA microplates, which were 
pre-coated by manufacturers with the antibodies specific 
to BAP or OC (sandwich ELISA). Then, biotin-conjugated 
polyclonal antibodies specific to BAP or OC were added fol-
lowed by the addition of Avidin conjugated to horseradish 
peroxidase (HRP) in the case of muALPL ELISA or sec-
ondary antibodies conjugated to HRP in the case of muOC 
ELISA. The 3,3′,5,5′-tetramethylbenzidine (TMB) was used 
a substrate for HRP. The enzyme-substrate reaction was ter-
minated by the addition of a sulfuric acid solution and the 
absorbance was spectrophotometrically measured at a wave-
length of 450 nm. BAP concentration (early differentiation 
marker) was determined on the 13th day of the experiment in 
the cell lysates prepared according to the procedure described 
earlier [29]. Concentration of intact OC (late differentiation 
marker) was determined on the 13th and 21st day in the cell 
culture supernatants.
MC3T3-E1 mineralization (the last stage of osteogenic 
differentiation) was assessed on the 21st day by determina-
tion of deposition of calcium phosphates in the extracellular 
matrix (ECM). Briefly, preosteoblasts were gently washed 
with HBSS without calcium and magnesium and the cells 
were decalcified by addition of 40 µl of 0.5 M HCl (Avantor 
Performance Materials Poland). Afterwards, the plates were 
sealed with parafilm to avoid evaporation and stored at 4 °C 
for at least 24 h (or until use). Calcium and phosphate con-
centrations in the samples were determined by colorimetric 
methods using commercially available Ca2+ and HPO2−4  
detection kits (BioMaxima Poland).
2.3. Statistical analysis
All tests were repeated in at least two experiments which 
were performed in quadruplicate. The statistically significant 
results (considered at a probability of P  <  0.05) compared to 
the control untreated cells were determined using an unpaired 
t-test (GraphPad Prism 5, Version 5.03 Software).
3. Results
3.1. Cell viability
GAD treatment only slightly decreased cell viability regard-
less of the time of exposure (figure 2). Viability of cells was 
high (above 80%) which is considered as the threshold for 
cytotoxicity of tested compounds/stimulations, and thus 
indicating the non-toxicity of nitrogen plasma against these 
preosteoblastic cells. Interestingly, MC3T3-E1 cells left in 
HBSS for 3 h after GAD treatment showed higher viability 
(approx. 95%) than cells where HBSS was immediately 
replaced by cell culture medium (approx. 85%).
3.2. Cell proliferation
MC3T3-E1 cells exposed to GAD treatment revealed faster 
growth rate and shorter doubling time (in the range of 31–
33 h) compared to the control untreated cells (38–39 h) (table 
1). In the case of cells that had HBSS immediately changed 
after GAD treatment (t  =  0), enhanced proliferation was 
observed only after longer plasma exposure times (8 s and 
16 s). Moreover, when the longer GAD treatment was applied, 
faster proliferation was observed (figure 3(a)). On the 3rd 
day there were 17.13  ±  1.21  ×  103 control untreated cells, 
whereas after plasma exposure there were 19.89  ±  1.50  ×  103 
cells for 8 s treatment and 22.19  ±  2.13  ×  103 cells for 16 s 
GAD treatment. However, in the case of cells left in HBSS 
for 3 h after plasma treatment, RONS formed in HBSS pro-
moted preosteoblasts’ proliferation regardless of plasma 
exposure time (figure 3(b)). On the 3rd day there were approx. 
22–23  ×  103 cells for 4, 8, and 16 s GAD treatment, which 
was significantly more compared to the control untreated cells 
(16.62  ±  1.00  ×  103 cells).
Figure 2. Viability of MC3T3-E1 preosteoblasts upon exposure 
to GAD assessed by MTT assay (t  =  0—HBSS replaced with 
growth medium immediately after GAD treatment, t  =  3 h—
HBSS replaced with growth medium 3 h after GAD treatment); 
*significantly different results compared to the untreated control 
cells according to unpaired t-test, P  <  0.05.
Table 1. Doubling time (in hours) and growth rate (number of doublings per hour) calculated for MC3T3-E1 cells after exposure to GAD.
Proliferation parameters
t  =  0 t  =  3 h
Control 4 s 8 s 16 s Control 4 s 8 s 16 s
Doubling time 38 41 33 33 39 32 31 32
Growth rate 0.0182 0.0169 0.0210 0.0209 0.0175 0.0215 0.0221 0.0213




Microscopy observation of cells revealed that plasma treat-
ment did not affect morphology of MC3T3-E1 preosteo-
blasts regardless of plasma exposure time and incubation 
period in HBSS (t  =  0 or t  =  3 h). Sample images are pre-
sented in figure 4. Both untreated and plasma-exposed cells 
were well spread and had extensive cytoskeleton structure. 
Importantly, nitrogen plasma did not exert any negative effect 
on MC3T3-E1 morphology.
3.4. Osteogenic differentiation
On the 13th day of the experiment it was observed that nitrogen 
plasma slightly (but statistically significantly) increased BAP 
and OC concentration only in the case of MC3T3-E1 cells 
exposed to plasma for 16 s and left in HBSS for 3 h after GAD 
treatment (figures 5 and 6(a)). Concentration of BAP and OC 
in untreated control cultures was equal to 3.67  ±  0.09 ng ml−1 
and 10.37  ±  0.38 ng ml−1, respectively, whereas concentra-
tion of BAP and OC in GAD-treated cultures (16 s, t  =  3 h) 
was equal to 4.68  ±  0.21 ng ml−1 and 13.37  ±  0.73 ng ml−1, 
respectively. On the 21st day of the experiment, OC syn-
thesis was significantly enhanced compared to the control 
cells (approx. 13 ng ml−1) in all GAD-treated MC3T3-E1 
cells with HBSS exchanged after 3 h (approx. 16–17 ng ml−1) 
Figure 3. Proliferation of MC3T3-E1 preosteoblasts upon exposure to GAD assessed by WST-8 assay: (a) HBSS replaced with growth 
medium immediately after GAD treatment, (b) HBSS replaced with growth medium 3 h after GAD treatment; *significantly different results 
compared to the untreated control cells according to unpaired t-test, P  <  0.05.
Figure 4. Images presenting morphology of control untreated preosteoblasts and MC3T3-E1 cells after 16 s GAD treatment and HBSS 
replaced with growth medium 3 h after plasma exposure (red fluorescence—F-actin filaments of cell cytoskeleton, blue fluorescence—cell 
nuclei).
Figure 5. BAP concentration in MC3T3-E1 cultures upon exposure 
to GAD assessed by ELISA; *significantly different results 
compared to the untreated control cells according to unpaired t-test, 
P  <  0.05.
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and in preosteoblasts treated with plasma for 16 s with HBSS 
exchanged immediately after exposure (approx. 17 ng ml−1) 
(figure 6(b)).
RONS formed after GAD treatment negatively affected 
ECM mineralization in preosteoblasts even after short 4 s 
plasma exposure time. MC3T3-E1 cells treated with plasma 
for 16 s (both t  =  0 and t  =  3 h) revealed almost 2-fold lower 
Ca2+ amount (approx. 0.7 µg) compared to the untreated cells 
(approx. 1.4 µg) (figure 7(a)). Phosphate amount detected in 
GAD-treated cultures (approx. 2.7-2.9 µg) was reduced by 
approx. 15%–20% compared to untreated control preosteo-
blasts (approx. 3.4 µg) (figure 7(b)). Moreover, the longer the 
GAD treatment was applied, the lower the amounts of cal-
cium and phosphate ions were determined, which was clearly 
observed in the case of cultures left for 3 h in HBSS after 
plasma exposure.
4. Discussion
Hydroxyl radicals, hydrogen peroxide (H2O2), and super-
oxide belong to reactive oxygen species (ROS) which may 
be produced under various physiological (e.g. natural process 
of aging) as well as pathological conditions (e.g. cerebellar 
ischemia, atherosclerosis, sunburns). Excessive ROS genera-
tion may induce oxidative stress causing cell injury and death. 
Nevertheless, some reports identified also the crucial role of 
ROS in the regulation of cell metabolism, proliferation, and 
differentiation [33].
Plasma is known to have ability to generate different reac-
tive species showing a variety of biological activities, like 
promotion of wound healing process or prevention against 
microbial infections. Importantly, these biological actions 
of plasma were primarily observed in liquid environment 
Figure 6. OC production by MC3T3-E1 preosteoblasts assessed by ELISA: (a) OC concentration determined 13 d after exposure to 
GAD, (b) OC concentration determined 21 d after exposure to GAD; *significantly different results compared to the untreated control cells 
according to unpaired t-test, P  <  0.05.
Figure 7. Mineralization of MC3T3-E1 osteoblasts upon exposure to GAD assessed by colorimetric methods via determination of Ca2+ 
and HPO2−4  amounts in the cultures: (a) Ca
2+ amounts in MC3T3-E1 cultures, (b) HPO2−4  amounts in MC3T3-E1 cultures; 
*significantly 
different results compared to the untreated control cells according to unpaired t-test, P  <  0.05.
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indicating that reactive species produced by plasma in the gas 
phase can be transferred through diffusion and secondary reac-
tions to a liquid, to produce singlet oxygen (1O2), hydroxyl 
radicals (OH), nitric oxide radicals (NO), hydrogen peroxide 
(H2O2), etc [34]. Moreover, it is known that plasma gener-
ates different RONS in liquids depending on the substrate gas 
used. Takamatsu et al used in their experiment the multi-gas 
plasma jet which generated (at low gas temperatures) atmos-
pheric plasma of oxygen, argon, nitrogen, carbon dioxide, 
helium, and air. They measured and compared concentra-
tions of various reactive species (1O2, OH radicals, H radicals, 
and NO radicals) formed by different plasmas in a solution 
(phosphate buffered saline, PBS). The results demonstrated 
that nitrogen plasma produced the largest amount of OH 
radicals (which may further react to form H2O2) among all 
tested homo-atomic gas species. Moreover, nitrogen plasma 
was also proved to generate large amounts of H and NO radi-
cals [34]. Different works have shown that a variety of RONS 
are formed in liquids depending on their composition and the 
plasma parameters, and usually higher amounts of RONS are 
formed in cell culture media due to the rich content in biomol-
ecules [35].
In this research, it was shown that the interaction of nitrogen 
plasma with HBSS and the cells significantly enhanced 
proliferation of MC3T3-E1 preosteoblasts (table 1, figure 3). 
In other works different mechanisms have been pointed out. 
Kalghatgi et al demonstrated that 30 s exposure of endothelial 
cells to non-thermal dielectric barrier discharge (DBD) air 
plasma significantly enhanced their proliferation due to ROS-
mediated fibroblast growth factor-2 (FGF-2) release. They 
implied that FGF-2 release upon plasma treatment was most 
likely related to generation of neutral ROS, like O3, NO, H2O2, 
or OH [36]. It should be noted that FGF-2 is also produced 
by osteoblastic cells and is known to regulate osteoblast 
functions by acting as an autocrine or paracrine signal for 
bone cells [37, 38]. Moreover, Dupree et al proved that FGF-2 
possesses the ability to enhance proliferation potential of 
osteoblasts and bone marrow-derived mesenchymal stem cells 
[39]. Thus, it may be assumed that the observed enhanced 
preosteoblasts’ proliferation probably resulted here also from 
RONS-mediated FGF-2 release. Nevertheless, Tominami 
et al showed that although cold atmospheric helium plasma 
generated large amount of H2O2, OH, and superoxide anion 
radicals, they did not have any positive effect on proliferation 
of MC3T3-E1 preosteoblasts [29].
Other available in the literature works employing plasma 
jet exposure of osteoblast-like cells (osteosarcoma-derived 
cells) were related to apoptotic death of tumor cells. In that 
case longer treatment times were used than here, which 
clearly indicates the importance of plasma dosing to either 
induce cytotoxicity [32, 40, 41] or enhance cell proliferation, 
as in our work. Even shorter treatment times with other kinds 
of sources, such as the well-established kINPen may lead to 
apoptotic cell death (only 10 s treatment led to compromised 
viability of human peripheral blood mononuclear cell, and 
impaired proliferation of immune system T-cells) [42]. This 
clearly underlines the importance of the configuration and 
characteristics of the plasma source in the biological effects 
obtained.
The group of Freeman investigated chondrogenic and oste-
ogenic differentiation in different works. They showed that 
exposure of mesenchymal stem cells to short (10 s) micro-
second pulsed DBD increased ROS and ROS-associated 
signaling, enhancing both chondrogenic and osteogenic dif-
ferentiation [43]. Mechanisms were further investigated by 
treatment of CH3/10T1/2 mouse embryonic cells cultured on 
type I collagen which showed increased expression of adhe-
sion proteins (pFAK, FAK, Akt, Bcl-2) and activation of sur-
vival pathways (but very dependent on the plasma treatment 
conditions). In line with our findings, their results indicate 
plasma-induced and RONS-mediated chondrogenic differen-
tiation and bone formation [44].
Similarly, in the present study, it was also demonstrated 
that nitrogen plasma treatment of preosteoblasts increased 
BAP (only for 16 s, t  =  3 h) and OC concentration (figures 
5 and 6) but inhibited cell mineralization (figure 7) in an 
irradiation-time-dependent manner. BAP is an early marker 
of bone formation process and its highest concentration is 
observed during the second phase of osteogenic differentiation 
(ECM synthesis stage). Unlike BAP, OC is the marker of 
the late stage of osteogenic differentiation associated with 
ECM mineralization since OC is a mineral binding protein. 
Nevertheless, OC is also produced by osteoblasts during the 
second stage of differentiation [45–47]. Interestingly, despite 
increased OC concentration detected in plasma-treated 
cultures, ECM mineralization was significantly reduced. Arai 
et  al demonstrated that MC3T3-E1 cells exposed to non-
toxic concentrations of H2O2 revealed significantly increased 
expression of genes for OC and at the same time 2-fold lower 
mineralization level compared to the untreated cells. They 
assumed that H2O2 caused up-regulation of antioxidant system 
altering osteogenic gene expression [33]. Therefore, it may 
be suggested that nitrogen plasma treatment of MC3T3-E1 
cells caused RONS-related change in the expression of 
osteogenic genes, promoting mainly the second stage of the 
differentiation process—ECM synthesis, and inhibiting the 
last stage—ECM mineralization. However, contrary results 
were obtained by Tominami et al who demonstrated that cold 
atmospheric helium plasma treatment (generating H2O2, OH, 
and superoxide anion radicals) of MC3T3-E1 preosteoblasts’ 
resulted in enhanced mineralization and increased BAP 
activity [29]. Nevertheless, it should be noted that application 
of helium gas undoubtedly resulted in the formation of 
different RONS (at different concentrations) from that formed 
after nitrogen plasma.
The effect of reactive species generated by various plasmas 
on living cells may be very complex at the molecular level. 
Moreover, it is known that the nature and concentration of 
reactive species formed after plasma exposure may vary a 
lot depending on the substrate gas used for the experiments, 
experimental setup (type of plasma reactor), the distance 
(height) between the electrodes and the liquid, or the type 
of plasma activated liquid. All this parameters which modify 
plasma-induced RONS, but also the electromagnetic fields and 
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UV–vis radiation in contact with the biological system have 
an impact on cell proliferation and differentiation in vitro. No 
exact plasma system as the one presented here with nitrogen 
has been employed, although some of the mechanisms 
discussed may be extrapolated to the modulation of osteoblast 
behavior, and be used to further investigate in this line.
5. Conclusion
Presented results clearly demonstrated that short-time 
nitrogen plasma treatment is non-toxic to the MC3T3-E1 
cells, does not affect cell morphology, promotes proliferation 
of preosteoblasts, enhances osteogenic differentiation by 
increasing BAP and OC concentration, but inhibits ECM 
mineralization process. During plasma treatment, oxygen 
and nitrogen radicals are formed, which have great impact 
on cell behavior. Thus, the best results were achieved for 16 s 
exposure time and when the preosteoblasts were left in HBSS 
for 3 h after plasma treatment. Based on the results obtained 
it may be inferred that short-time cold atmospheric nitrogen 
plasma treatment appears to have great clinical potential to be 
used in regenerative medicine applications for improvement 
of bone healing process by promotion of preosteoblasts’ 
proliferation and bone ECM synthesis.
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